S3 SHOULDER PLATE 11 HOLE RIGHT
Report
- Report Number
- 1818910-2011-08800
- Event Type
- Malfunction
- Date Received
- May 17, 2011
- Date of Event
- April 18, 2011
- Report Date
- April 18, 2011
- Manufacturer
- DEPUY ORTHOPAEDICS, INC.
- Product Code
- LXT
- PMA / PMN Number
- K060290
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- OTHER
Narratives
THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A LOT SPECIFIC COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE AS THE LOT CODE REQUIRED FOR THE PLATE AND THE PART/LOT CODES REQUIRED FOR THE SCREWS WERE NOT PROVIDED. A PREVIOUS INVESTIGATION FOUND ALTHOUGH THE COMPLAINT IS NON-VERIFIABLE, THERE ARE PREVIOUS COMPLAINTS FOR THIS FAILURE MODE. PT ANATOMY AND SURGICAL TECHNIQUE CAN IMPACT THE PEG ENGAGEMENT EVEN IF THE PRODUCT IS WITHIN SPEC. THIS IS DISCUSSED IN DVA-104443-DFMEA AND DVA-10443-RMR AND IS APPROVED WITH AN IFR (INVESTIGATE FURTHER REDUCTION) DESIGNATION. THE ENGAGEMENT ISSUES ARE IMPACTED BY PT ANATOMY AND SURGICAL TECHNIQUE. ALTHOUGH THE RISK IS CONSIDERED ACCEPTABLE PER THE RMR (RISK MANAGEMENT REPORT), PRODUCT DEVELOPMENT, QUALITY AND MARKETING ARE INVESTIGATION WAYS TO FURTHER REDUCE THE OCCURRENCE OF PEG ENGAGEMENT ISSUES. (B)(4) WAS OPENED ON (B)(4) 2011 TO DETERMINE IF ANY ADD'L ACTIONS MAY DECREASE THE LIKELIHOOD OF PEG ENGAGEMENT ISSUES. ANY ROOT CAUSE AND/OR CORRECTIVE ACTIONS WILL BE DOCUMENTED IN (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ANY ADD'L INFO BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.
SCREWS WOULD NOT LOCK INTO THE PLATE. THIS RESULTED IN A SURGICAL DELAY OF 30-45 MINUTES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | S3 SHOULDER PLATE 11 HOLE RIGHT | 87 LXT | LXT | DEPUY ORTHOPAEDICS, INC. | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR |